Zum Inhalt springen
Global sound
BioSpace

BioSpace

Fragile X at a turning point: Breaking through the clinical bottleneck

· 19 Min.

Shownotes

In this episode of Denatured, you’ll hear from Hilary Rosselot, executive director at the National Fragile X Foundation and Jordi Fàbrega, co-founder & CEO at CONNECTA Therapeutics. From trial endpoints and placebo effects to neuroplasticity modulation, we explore what it will take to build a sustainable path to the first approved therapy.

Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests
Hilary Rosselot, Executive Director, National Fragile X Foundation
Jordi Fàbrega, Co-Founder & CEO, CONNECTA Therapeutics

Disclaimer: The views expressed in this discussion by guests…

Live, letzte Stunde: 11.790 Songs auf 4.863 Sendern in 117 Ländern

Entdecke die Welt über das Radio

Mehr zum Entdecken (7)

Etwas Schönes gehört? Speicher es oder öffne es direkt in Spotify.

★ Künstler der Woche Der schnellste Aufsteiger im Radio diese Woche
Dein Song hier? Ab € 9 pro Woche →
radio sportWeiterhören